DMK Pharmaceuticals Corporation
DMKPQ
$0.00
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | 31.88% | -99.53% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 31.88% | -99.53% | |||
| Cost of Revenue | -6.34% | -79.79% | |||
| Gross Profit | 7.05% | -5.76% | |||
| SG&A Expenses | -8.85% | -44.94% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.35% | -57.22% | |||
| Operating Income | 6.43% | 47.66% | |||
| Income Before Tax | 75.21% | 22.31% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 75.21% | 22.31% | |||
| Earnings from Discontinued Operations | 122.17% | -2,290.66% | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 83.81% | 4.12% | |||
| EBIT | 6.43% | 47.66% | |||
| EBITDA | 5.98% | 48.13% | |||
| EPS Basic | 94.23% | 16.84% | |||
| Normalized Basic EPS | -162.89% | 108.83% | |||
| EPS Diluted | 94.23% | 18.31% | |||
| Normalized Diluted EPS | -162.89% | 108.83% | |||
| Average Basic Shares Outstanding | 174.99% | 17.62% | |||
| Average Diluted Shares Outstanding | 174.99% | 17.62% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||